VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,712,637 | -7.8% | 63,643 | +3.1% | 0.01% | -7.1% |
| Q2 2023 | $1,858,514 | -10.6% | 61,724 | -4.0% | 0.01% | -12.5% |
| Q1 2023 | $2,079,333 | +39.9% | 64,276 | +24.0% | 0.02% | +33.3% |
| Q4 2022 | $1,486,000 | +30.0% | 51,842 | +9.4% | 0.01% | +20.0% |
| Q3 2022 | $1,143,000 | -24.0% | 47,368 | -13.7% | 0.01% | -16.7% |
| Q2 2022 | $1,503,000 | -27.8% | 54,891 | +1.1% | 0.01% | -14.3% |
| Q1 2022 | $2,082,000 | +15.7% | 54,285 | -3.4% | 0.01% | +16.7% |
| Q4 2021 | $1,799,000 | +20.3% | 56,181 | +10.6% | 0.01% | +9.1% |
| Q3 2021 | $1,495,000 | -11.5% | 50,793 | +2.1% | 0.01% | -15.4% |
| Q2 2021 | $1,689,000 | +9.8% | 49,764 | +5.2% | 0.01% | -7.1% |
| Q1 2021 | $1,538,000 | -4.6% | 47,308 | +5.7% | 0.01% | -12.5% |
| Q4 2020 | $1,612,000 | -22.8% | 44,748 | -16.1% | 0.02% | -30.4% |
| Q3 2020 | $2,089,000 | -34.9% | 53,348 | -39.1% | 0.02% | -41.0% |
| Q2 2020 | $3,211,000 | +507.0% | 87,529 | +281.1% | 0.04% | +387.5% |
| Q1 2020 | $529,000 | -21.5% | 22,969 | -0.2% | 0.01% | +14.3% |
| Q4 2019 | $674,000 | +58.6% | 23,012 | +38.5% | 0.01% | +40.0% |
| Q3 2019 | $425,000 | -2.3% | 16,616 | -2.4% | 0.01% | 0.0% |
| Q2 2019 | $435,000 | +16.6% | 17,016 | +2.3% | 0.01% | 0.0% |
| Q1 2019 | $373,000 | +30.4% | 16,641 | +22.9% | 0.01% | +25.0% |
| Q4 2018 | $286,000 | +36.2% | 13,541 | +19.4% | 0.00% | +100.0% |
| Q3 2018 | $210,000 | -99.9% | 11,341 | -13.7% | 0.00% | -50.0% |
| Q1 2018 | $288,883,000 | +43.8% | 13,143 | +52.1% | 0.00% | +100.0% |
| Q4 2017 | $200,863,000 | -90.5% | 8,643 | -90.6% | 0.00% | -92.6% |
| Q3 2017 | $2,110,942,000 | +2.8% | 91,940 | -1.1% | 0.03% | 0.0% |
| Q2 2017 | $2,052,645,000 | +788.5% | 92,964 | +741.8% | 0.03% | +800.0% |
| Q1 2017 | $231,019,000 | +109909.0% | 11,043 | +9.9% | 0.00% | 0.0% |
| Q4 2016 | $210,000 | -100.0% | 10,050 | -86.3% | 0.00% | -89.7% |
| Q3 2016 | $1,936,816,000 | -66.9% | 73,281 | -65.3% | 0.03% | -67.4% |
| Q2 2016 | $5,847,143,000 | – | 211,012 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |